This information was published on 2025-06-10T15:15:34 for IP Right Acceptance Published.
| Field | Value |
| (210) | 2552386 |
| (220) |
30 May 2025
|
| (300) |
US, 02 Dec 2024, 98880590
|
| (511) (510) |
Class 5
Pharmaceutical and biological preparations for human use. |
| (540) | REXHILZA |
| (550) | Word |
| (730) |
Bristol-Myers Squibb Company
|
| (750) |
Spruson & Ferguson
|
Find out more about publications on the About page.